15762 Results

People

  1. Hudis
    Hudis
  2. Offit
    Offit
  3. Zelefsky
    Zelefsky
  4. Giralt
    Giralt
  5. Robson
    Robson
  6. Yahalom
    Yahalom
  7. Wolden
    Wolden
  8. Coit
    Coit
  9. Marghoob
    Marghoob
  10. Tuttle
    Tuttle

Groups

  1. Survivorship Research (15762)
  2. Department of Medicine (9201)
  3. Population Sciences Research Program (5670)
  4. Solid Tumor Oncology Division (5183)
  5. Surgery (5130)
  6. Epidemiology and Biostatistics (3598)
  7. Division of Subspecialty Medicine (3242)
  8. Center for Hematologic Malignancies (2610)
  9. Biostatistics Service (2488)
  10. GSK Faculty (2413)
  1. "Survivorship Research"
Formats
  1. Journal Article (8899)
  2. Meeting Abstract (5192)
  3. Book Section (571)
  4. Review (357)
  5. Editorial (225)
  6. Research Letter (132)
  7. Conference Paper (104)
  8. Correspondence (91)
  9. Guidelines (85)
  10. Miscellaneous (76)
  11. Book Whole (30)
Groups
  1. Survivorship Research (15762)
  2. Department of Medicine (9201)
  3. Population Sciences Research Program (5670)
  4. Solid Tumor Oncology Division (5183)
  5. Surgery (5130)
  6. Epidemiology and Biostatistics (3598)

More Groups

People
  1. Clifford Hudis (905)
  2. Kenneth Offit (788)
  3. Michael Zelefsky (754)
  4. Sergio Giralt (684)
  5. Mark Robson (676)
  6. Joachim Yahalom (625)

More People

Years
  1. 2025 (231)
  2. 2024 (802)
  3. 2023 (892)
  4. 2022 (906)
  5. 2021 (922)
  6. 2020 (930)

More Years

Publications
  1. Journal of Clinical Oncology (1873)
  2. International Journal of Radiation Oncology, Biology, Physics (908)
  3. Blood (685)
  4. Annals of Surgical Oncology (599)
  5. Cancer Research (333)
  6. Cancer (331)

More Publications

Publishers
  1. Elsevier Inc. (2658)
  2. American Society of Clinical Oncology (2019)
  3. Springer (1542)
  4. Wiley Blackwell (806)
  5. Oxford University Press (787)
  6. American Society of Hematology (748)

More Publishers

Results (15762)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Fludarabine-based conditioning secures engraftment of secondary hematopoietic stem cell allografts (HSCT) used to treat graft failure
    Meeting Abstract

    Chewning, J. H.; Castro-Malaspina, H. R.; Hsu, K.; Jakubowski, A. A.; Kernan, N. A.; Papadopoulos, E. B.; Perales, M. A.; Prockop, S. E.; Small, T. N.; van den Brink, M. R. M.; more...
    Biology of Blood and Marrow Transplantation (2005)

    Fulltext@MSK | Save
  • Improved oncologic outcome following a pathologic complete response of rectal cancer to preoperative combined modality therapy
    Meeting Abstract

    Chessin, D. B.; Stipa, F.; Shia, J.; Paty, P. B.; Weiser, M. R.; Temple, L. K.; Saltz, L.; Minsky, B. D.; Wong, W. D.; Guillem, J. G.
    Annals of Surgical Oncology (2005)

    Fulltext@MSK | Save
  • Modulation of tumor hypoxia proteins in rectal cancer undergoing preoperative chemoradiation
    Meeting Abstract

    Chessin, D. B.; Pucciarelli, S.; Shia, J.; Riedel, E.; Moore, H. G.; Guillem, J. G.
    Journal of the American College of Surgeons (2005)

    Fulltext@MSK | Save
  • Positron emission tomography during preoperative combined modality therapy for rectal cancer may predict ultimate pathologic response: A prospective analysis
    Meeting Abstract

    Chessin, D. B.; Akhurst, T.; Yeung, H.; Shia, J.; Riedel, E.; Paty, P. B.; Saltz, L.; Minsky, B. D.; Larson, S.; Guillem, J. G.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Intensity modulated radiation therapy (IMRT) for nasopharynx cancer: Update of the Memorial Sloan-Kettering experience
    Meeting Abstract

    Chen, W. C. Y.; Zelefsky, M. J.; Pfister, D. G.; Berry, S. L.; Kraus, D. H.; Wolden, S. L.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Sensorineural hearing loss in combined modality treatment of nasopharyngeal carcinoma
    Meeting Abstract

    Chen, W. C.; Jackson, A.; Budnick, A. S.; Pfister, D. G.; Kraus, D. H.; Hunt, M. A.; Wolden, S. L.
    International Journal of Radiation Oncology, Biology, Physics (2005)

    Fulltext@MSK | Save
  • Serum HER-2/neu has clinical utility in monitoring and prediction of progression-free survival in metastatic breast cancer patients treated with trastuzamab-based therapies
    Meeting Abstract

    Cheli, C. Q.; Esteva, F. J.; Fritsche, H.; Fornier, M.; Slamon, D.; Thiel, R. P.; Lueftner, D.; Ghani, F.
    Clinical Chemistry (2005)

    Fulltext@MSK | Save
  • Induction of remission prior to transplantation improves the disease-free survival (DFS) of patients with advanced myelodysplastic syndromes (MDS) treated with myeloablative T-cell depleted (TCD) stem cell transplants (SCT) from HLA identical siblings
    Meeting Abstract

    Castro-Malaspina, H. R.; Jakubowski, A. A.; Papadopoulos, E. B.; Boulad, F.; Young, J. W.; Kernan, N. A.; Perales, M. A.; Small, T. N.; Hsu, K. C.; Chiu, M.; more...
    Blood (2005)

    Fulltext@MSK | Save
  • Post-chemotherapy retroperitoneal lymph node dissection for non-seminomatous germ cell tumors: The impact of time
    Meeting Abstract

    Carver, B. S.; Motzer, R. J.; Bajorin, D.; Stasi, J.; Bosl, G. J.; Sheinfeld, J.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Utility of breast MRI in patients with occult primary breast cancer
    Meeting Abstract

    Buchanan, C. L.; Morris, E. A.; Dorn, P.; Borgen, P.; Van Zee, K. J.
    Annals of Surgical Oncology (2005)

    Fulltext@MSK | Save